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Lessons from Practice
serology and thyroid function tests were normal. Parapro
electrophoresis. Magnetic resonance imaging (MRI) of th
patchy periventricular areas of high signal not suggestive
Her systemic symptoms of fever, sweats and weight loss 
doses of cyclophosph mide (1 g/m2), despite worsening 
After 3 months, the patient relapsed with recurrence of p
progressively rose to 838 U/L. Neuropathy progressed to
walk. Reflexes were lost, with a glove-and-stocking patteoe
ma
in C liac disease is associated with an increased risk oflignancy.1 Most of these tumours are T-cell lymphomas,contrast to the common sporadic B-cell lymphomas that
usually occur in the gastrointestinal tract.
Enteropathy-associated T-cell lymphoma (EATL) often presents
as refractory sprue. The risk of EATL usually decreases to a low
level after adhering to a gluten-free diet for 5 years. Common
symptoms of presentation include diarrhoea, abdominal pain and
weight loss. Patients may also present with acute bleeding, perfora-
tion or obstruction.2 Our patient presented with weight loss,
pyrexia and, subsequently, neuropathy. Clinical deterioration
despite compliance with a gluten-free diet should raise suspicion
of EATL. Conversely, as coeliac disease may be undiagnosed at the
time of presentation of the intestinal lymphoma, patients with T-
cell lymphoma or a gut primary localisation should be tested for
coeliac disease. Endoscopy with biopsy is usually the test of
choice. Laparotomy is performed in some instances, especially
when patients present with an acute abdomen.
Our case illustrates a number of interesting features. First, a
definitive diagnosis of EATL may be elusive, and persistence in
2 Positive CD3 immunostaining of 
lymphocytes
Clinical record
A 53-year-old woman with a 10-year history of coeliac disease controlled by a gluten-free 
diet presented with a 6-month history of dramatic weight loss and pyrexia. Physical 
examination showed wasting and peripheral oedema. Plasma albumin level was 23 g/L 
(normal, 34–48 g/L). Computed tomography of head, neck, chest, abdomen and pelvis, 
gallium and positron emission tomography scans, liver biopsy and bone marrow biopsy 
were normal. The serum lactate dehydrogenase (LDH) level was 466 U/L (normal, 
110–230 U/L), raising the possibility of occult malignancy, especially enteropathy-
associated T-cell lymphoma (EATL). Endoscopic duodenal biopsy revealed mild increase 
in intraepithelial lymphocytes, crypt hyperplasia and villous abnormality in keeping with 
coeliac disease. Molecular clonality studies of the lymphoid cells in the duodenal biopsy 
yielded a monoclonal band of T-cell receptor (TCR) γ gene rearrangement in two separate 
series of biopsies taken 6 weeks apart.
Refractory sprue was diagnosed, and the patient received sequential trials of 
prednisolone, cyclosporin A and infliximab without benefit. High dose cyclophosphamide 
(2 g/m2) was administered 3 months later for presumed EATL. This resulted in immediate 
resolution of the fever and improved weight gain.
The patient subsequently complained of paraesthesiae in her feet. Neurological 
examination was normal. Nerve conduction studies suggested an early axonal sensory 
peripheral neuropathy. Vitamin B12, folate, vitamin A-tocopherol, red blood cell 
transaminase and transketolase studies, vasculitic screen, glycated haemoglobin, syphilis 
tein was not detected in serum 
e brain showed non-specific 
 of the suspected lymphoma. 
responded to two further 
neurological symptoms.
yrexia, and the serum LDH level 
 the point where she could not 
rn of sensorimotor disturbance. 
A repeated nerve conduction study confirmed severe axonal sensorimotor peripheral 
neuropathy affecting both upper and lower limbs. Cerebrospinal fluid was normal, and 
there were no malignant cells. Repeated investigations, including brain MRI and upper 
gastrointestinal endoscopy, did not reveal any further evidence of malignancy.
A right sural nerve biopsy showed severe loss of myelinated nerve fibres, and many of the 
surviving fibres showed varying stages of axonal degeneration (Box 1) associated with a 
sparse, patchy endoneurial mononuclear cell infiltrate in some fascicles and prominent 
endoneurial fibrosis on trichrome stain. The CD45RB immunostain showed increased 
numbers of immunopositive endoneurial lymphoid cells that showed immunopositivity 
with the T-cell markers CD3 (Box 2) and CD5. The CD68 immunostain showed increased 
endoneurial macrophages, and ultrastructural assessment confirmed macrophage 
phagocytosis of degenerate myelinated fibres. CD20 immunostain was negative. The 
Congo red stain for amyloid was negative. A TCRγ clonality study of the nerve biopsy 
showed a monoclonal band identical to the previous band detected in the duodenal 
biopsies, confirming infiltration of the nerve by T-cell lymphoma (Box 3).
Subsequent treatment with cyclophosphamide, doxorubicin and dexamethasone was 
complicated by Enterococcus faecalis septicaemia and florid disseminated intravascular 
coagulation, leading to the patient’s death.
1 Nerve fibres in varying stages of 
axonal degeneration
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LESSONS FRO M PRACTICEobtaining histological confirmation is
warranted. The elevated serum lactate
dehydrogenase (LDH) level raised the
possibility of an underlying malignancy.
Second, in patients with refractory sprue,
a clonal TCRγ rearrangement often pre-
cedes the onset of overt T-cell lymphoma,
which constitutes an early or cryptic form
of EATL.3-5 The difficulty is distinguishing
antigen-dependent T cells from neoplastic
T cells. Management decisions may have
to be based on DNA clonality studies
alone. Finally, although central nervous
system involvement has been reported,6,7
to our knowledge this is the first reported
case of peripheral nerve involvement in
EATL. Clinical evidence of peripheral
neuropathy is observed in 0.1% to 8% of
patients with malignant lymphomas,8 and
neurotoxic chemotherapeutic agents are
frequently presumed to be the cause.
Peripheral nerve involvement in T-cell
lymphomas is very uncommon.8-10 It is
also interesting that the infiltrative neu-
ropathy progressed relentlessly despite an
initial good response of systemic symp-
toms to cyclophosphamide.
Both refractory sprue and EATL carry a
very poor prognosis, with a 5-year survival
rate of 11%. This is related to the unre-
sponsive malabsorption in cryptic EATL,
which is often diagnosed late. Associated
malabsorption and malnutrition make tol-
erance of chemotherapy difficult, and
treatment-related complications such as
gastrointestinal bleeding and perforation also worsen prognosis.2
Favourable outcomes with multi-drug therapy generally occur in
patients who have minimal gastrointestinal symptoms before the
diagnosis of lymphoma and can tolerate therapy.
Chemotherapy should be considered for all patients and should
constitute drugs active in intermediate- and high-grade lym-
phoma. A variety of regimens, including CHOP (cyclophospha-
mide, doxorubicin, vincristine and prednisolone), have been used.
The optimal cytotoxic regimen is unclear, as data are limited to
uncontrolled retrospective case series. The role of salvage treat-
ments and high-dose chemotherapy at relapse also remains to be
investigated.2 Earlier diagnosis and development of more effective
treatments are required to improve the outcome for these patients.
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3 Polyacrylamide gel electrophoresis of 
T-cell receptors
Lane 1, positive control; lane 2, negative control; lane 
3, normal (polyclonal) control; lanes 4 and 5, duodenal 
biopsy, 12 Apr 2002; lanes 6 and 7, duodenal biopsy, 
19 Jul 2002; lanes 8 and 9, nerve tissue, 9 Oct 2002.
Lessons from practice
• Coeliac disease is associated with an 
increased risk of malignancy, especially 
intestinal lymphoma or enteropathy-
associated T-cell lymphoma (EATL).
• EATL often presents as refractory sprue, but 
definitive diagnosis may be difficult and 
requires T-cell clonality studies.
• Earlier diagnosis and development of more 
effective treatments are warranted to 
improve the poor outcome in these patients.MJA • Volume 182 Number 7 • 4 April 2005 349
